Literature DB >> 26958155

Recurrent Transcortical Motor Aphasia-Another CNS Infectious Syndrome Associated with Herpes Virus Infection.

Raghav Govindarajan1, Efrain Salgado1.   

Abstract

Herpes simplex encephalitis is an acute/subacute illness that causes both general and focal signs of cerebral dysfunction with fever, headache, and confusion as cardinal features. Recurrent herpes simplex meningitis, also known as Mollaret's meningitis, is another manifestation of central nervous system herpetic infection with recurrent episodes of fever, headache, and nuchal rigidity associated with cerebrospinal fluid (CSF) evidence of active herpes simplex infection. Bell's palsy is yet another manifestation of a herpes virus infection in at least some reported cases documented by CSF analysis. We report a case of a 70-year-old male who presented with acute transcortical motor aphasia initiating a stroke work-up that was negative. Physical examination revealed genital vesicles, and the CSF was consistent with active herpes simplex infection.

Entities:  

Year:  2016        PMID: 26958155      PMCID: PMC4762403     

Source DB:  PubMed          Journal:  J Vasc Interv Neurol        ISSN: 1941-5893


  4 in total

1.  Selective language aphasia from herpes simplex encephalitis.

Authors:  A Ku; E A Lachmann; W Nagler
Journal:  Pediatr Neurol       Date:  1996-09       Impact factor: 3.372

2.  Re-evaluating the diagnostic methods in herpes simplex encephalitis.

Authors:  Amer Al-Shekhlee; Naira Kocharian; Jose J Suarez
Journal:  Herpes       Date:  2006-05

3.  Herpes simplex encephalitis. Clinical Assessment.

Authors:  R J Whitley; S J Soong; C Linneman; C Liu; G Pazin; C A Alford
Journal:  JAMA       Date:  1982-01-15       Impact factor: 56.272

4.  Diseases that mimic herpes simplex encephalitis. Diagnosis, presentation, and outcome. NIAD Collaborative Antiviral Study Group.

Authors:  R J Whitley; C G Cobbs; C A Alford; S J Soong; M S Hirsch; J D Connor; L Corey; D F Hanley; M Levin; D A Powell
Journal:  JAMA       Date:  1989-07-14       Impact factor: 56.272

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.